278 related articles for article (PubMed ID: 1939784)
1. HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups.
Ahmed I; Piepkorn M; Goldgar DE; Cannon-Albright LA; Meyer LJ; Skolnick MH; Zone JJ
J Cutan Pathol; 1991 Aug; 18(4):257-60. PubMed ID: 1939784
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of combining PRAME and HMB-45 stains in primary melanocytic tumors.
Rasic D; Korsgaard N; Marcussen N; Precht Jensen EM
Ann Diagn Pathol; 2023 Dec; 67():152211. PubMed ID: 37717457
[TBL] [Abstract][Full Text] [Related]
3. HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma.
Smoller BR; McNutt NS; Hsu A
Am J Surg Pathol; 1989 Aug; 13(8):680-4. PubMed ID: 2473661
[TBL] [Abstract][Full Text] [Related]
4. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
5. The dysplastic nevus: recognition and management.
Barnhill RL; Hurwitz S; Duray PH; Arons MS
Plast Reconstr Surg; 1988 Feb; 81(2):280-9. PubMed ID: 3275948
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
Lampert A; Thomine E; Lauret P; Hemet J
Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
[TBL] [Abstract][Full Text] [Related]
7. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
Roush GC; Barnhill RL
Br J Cancer; 1991 Nov; 64(5):943-7. PubMed ID: 1931621
[TBL] [Abstract][Full Text] [Related]
8. Prediction of histologic melanocytic dysplasia from clinical observation.
Roush GC; Dubin N; Barnhill RL
J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
[TBL] [Abstract][Full Text] [Related]
9. Fine structural and immunohistochemical properties of dysplastic melanocytic nevi: comparison with malignant melanoma.
Jimbow K; Horikoshi T; Takahashi H; Akutsu Y; Maeda K
J Invest Dermatol; 1989 May; 92(5 Suppl):304S-309S. PubMed ID: 2715663
[TBL] [Abstract][Full Text] [Related]
10. A hypothesis incorporating the histologic characteristics of dysplastic nevi into the normal biological development of melanocytic nevi.
Piepkorn M
Arch Dermatol; 1990 Apr; 126(4):514-8. PubMed ID: 2321996
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 and D3 expression in melanocytic skin lesions.
Alekseenko A; Wojas-Pelc A; Lis GJ; Furgał-Borzych A; Surówka G; Litwin JA
Arch Dermatol Res; 2010 Sep; 302(7):545-50. PubMed ID: 20496072
[TBL] [Abstract][Full Text] [Related]
12. Dysplastic nevi in relation to superficial spreading melanoma.
Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
[TBL] [Abstract][Full Text] [Related]
13. A retrospective look at dysplastic nevi. What were they in 1978 and how have they fared since?
Cockerell CJ; Berson DS
Am J Dermatopathol; 1985; 7 Suppl():93-7. PubMed ID: 3940095
[TBL] [Abstract][Full Text] [Related]
14. [Dysplastic melanocytic nevus].
Salava A; Ranki A; Saksela O
Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
[TBL] [Abstract][Full Text] [Related]
15. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity.
McNutt NS; Urmacher C; Hakimian J; Hoss DM; Lugo J
J Cutan Pathol; 1995 Dec; 22(6):502-17. PubMed ID: 8835170
[TBL] [Abstract][Full Text] [Related]
16. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
17. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.
Hastrup N; Hou-Jensen K
APMIS; 1993 Nov; 101(11):845-50. PubMed ID: 8286092
[TBL] [Abstract][Full Text] [Related]
18. Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives.
Albert LS; Rhodes AR; Sober AJ
J Am Acad Dermatol; 1990 Jan; 22(1):69-75. PubMed ID: 2298967
[TBL] [Abstract][Full Text] [Related]
19. Dysplastic melanocytic nevus: Are molecular findings the key to the diagnosis?
Xavier-Junior JCC; Ocanha-Xavier JP
Ann Diagn Pathol; 2022 Oct; 60():152006. PubMed ID: 35839551
[TBL] [Abstract][Full Text] [Related]
20. Tumor antigen expression in compound dysplastic nevi and superficial spreading melanoma defined by a panel of nevomelanoma monoclonal antibodies.
Lazzaro B; Strassburg A
Hybridoma; 1996 Apr; 15(2):141-6. PubMed ID: 8743294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
